| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Cytochrome P450 26B1 |
|---|
| Ligand | BDBM476235 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Cell-Based Inhibitor Assay |
|---|
| IC50 | 290±n/a nM |
|---|
| Citation |  Cameron, DA; Petkovich, M; Rantanen, TK; Snieckus, V; Board, J; Singh, S; Maheta, AJ Compounds and methods for inhibiting CYP26 enzymes US Patent US10874634 Publication Date 12/29/2020 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Cytochrome P450 26B1 |
|---|
| Name: | Cytochrome P450 26B1 |
|---|
| Synonyms: | CP26B_HUMAN | CYP26A2 | CYP26A2 | CYP26B1 | Cytochrome P450 26A2 | Cytochrome P450 26B1 | Cytochrome P450 retinoic acid-inactivating 2 | Cytochrome P450RAI-2 | P450RAI2 | Retinoic acid-metabolizing cytochrome |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 57525.03 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | ChEMBL_115648 |
|---|
| Residue: | 512 |
|---|
| Sequence: | MLFEGLDLVSALATLAACLVSVTLLLAVSQQLWQLRWAATRDKSCKLPIPKGSMGFPLIG
ETGHWLLQGSGFQSSRREKYGNVFKTHLLGRPLIRVTGAENVRKILMGEHHLVSTEWPRS
TRMLLGPNTVSNSIGDIHRNKRKVFSKIFSHEALESYLPKIQLVIQDTLRAWSSHPEAIN
VYQEAQKLTFRMAIRVLLGFSIPEEDLGHLFEVYQQFVDNVFSLPVDLPFSGYRRGIQAR
QILQKGLEKAIREKLQCTQGKDYLDALDLLIESSKEHGKEMTMQELKDGTLELIFAAYAT
TASASTSLIMQLLKHPTVLEKLRDELRAHGILHSGGCPCEGTLRLDTLSGLRYLDCVIKE
VMRLFTPISGGYRTVLQTFELDGFQIPKGWSVMYSIRDTHDTAPVFKDVNVFDPDRFSQA
RSEDKDGRFHYLPFGGGVRTCLGKHLAKLFLKVLAVELASTSRFELATRTFPRITLVPVL
HPVDGLSVKFFGLDSNQNEILPETEAMLSATV
|
|
|
|---|
| BDBM476235 |
|---|
| n/a |
|---|
| Name | BDBM476235 |
|---|
| Synonyms: | US10874634, Cmpd No. 17 | US11364220, Compound 17 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C26H35NO4S |
|---|
| Mol. Mass. | 457.625 |
|---|
| SMILES | CCC(CC)(C(O)=O)c1ccc(NS(=O)(=O)c2ccc3c(c2)C(C)(C)CCC3(C)C)cc1 |
|---|
| Structure | 
|
|---|
Search and Browse
